Skip Content
You are currently on the new version of our website. Access the old version .

12 Results Found

  • Feature Paper
  • Review
  • Open Access
682 Views
14 Pages

Portopulmonary Hypertension and Hepatopulmonary Syndrome: Contrasting Pathophysiology and Implications for Liver Transplantation

  • Vanja Silić,
  • Daniela Bandić Pavlović,
  • Feđa Džubur,
  • Ivan Romić,
  • Igor Petrović,
  • Goran Pavlek,
  • Jurica Zedelj,
  • Gzim Redžepi and
  • Miroslav Samaržija

22 December 2025

Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome (HPS) present two vascular complications of portal hypertension, which make opposite extremes occur against the same pathophysiological background. In PoPH, vasoconstriction predominates...

  • Article
  • Open Access
8 Citations
4,354 Views
16 Pages

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats

  • Ching-Chih Chang,
  • Chiao-Lin Chuang,
  • Ming-Hung Tsai,
  • I.-Fang Hsin,
  • Shao-Jung Hsu,
  • Hui-Chun Huang,
  • Fa-Yauh Lee and
  • Shou-Dong Lee

Hepatopulmonary syndrome (HPS) is a lethal complication of cirrhosis characterized by hypoxia and overt intrapulmonary shunting. In this study, we investigated the effect of caffeine in rats with common bile duct ligation (CBDL)-induced liver cirrhos...

  • Case Report
  • Open Access
1,501 Views
12 Pages

Cerebrovascular Accidents After Orthotopic Liver Transplantation in Patients with Hepatopulmonary Syndrome: A Case Series

  • Steffi K. Chan,
  • Manuel M. Buitrago Blanco,
  • Nicholas J. Feduska,
  • Vatche G. Agopian,
  • Samer S. Ebaid,
  • Tisha Wang,
  • Ami Tamhaney and
  • Igor Barjaktarevic

Background: Hepatopulmonary syndrome (HPS), defined by the presence of pulmonary vascular dilatations that cause right-to-left transpulmonary shunting of venous blood with a consequential increase in the alveolar–arterial oxygen gradient, is a...

  • Article
  • Open Access
2 Citations
1,986 Views
11 Pages

Vascular Extracellular Vesicles Indicate Severe Hepatopulmonary Syndrome in Cirrhosis

  • Sukriti Baweja,
  • Anupama Kumari,
  • Preeti Negi,
  • Swati Thangariyal,
  • P. Debishree Subudhi,
  • Shivani Gautam,
  • Ashmit Mittal and
  • Chhagan Bihari

Background: Hepatopulmonary syndrome (HPS) is a pulmonary vasculature complication in the setting of liver disease that is characterized by pathological vasodilation resulting in arterial oxygenation defects. We investigated the role of extracellular...

  • Review
  • Open Access
1 Citations
3,297 Views
18 Pages

Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management

  • Roberto G. Carbone,
  • Francesco Puppo,
  • Christopher A. Thomas and
  • Vincenzo Savarino

The common cause of porto-pulmonary hypertension and hepato-pulmonary syndrome is portal hypertension. Porto-pulmonary hypertension (PPHTN) is a form of pulmonary arterial hypertension, and hepato-pulmonary syndrome (HPS) occurs as a consequence of h...

  • Case Report
  • Open Access
2 Citations
907 Views
6 Pages

13 December 2017

This paper presents a case of a young patient with cyanosis and digital clubbing, until then an active, sporty person. He sought medical assistance due to the growing dyspnoea and the drop of effort tolerance. Initially the diagnostic process focused...

  • Case Report
  • Open Access
3 Citations
2,037 Views
8 Pages

4 August 2023

Background: Extracorporeal membrane oxygenation (ECMO) is an accommodation of the cardiopulmonary bypass technique that can support gas exchange and hemodynamic stability. It is used as a salvage maneuver in patients with life-threatening respiratory...

  • Article
  • Open Access
3 Citations
1,744 Views
11 Pages

Echocardiographic Screening of Liver Transplant Candidates—Prevalence of Features of Portopulmonary Hypertension

  • Olga Dzikowska-Diduch,
  • Tomasz Cader,
  • Krzysztof Jankowski,
  • Aisha Ou-Pokrzewińska,
  • Monika Sznajder,
  • Jan Siwiec,
  • Szymon Pucyło,
  • Aleksandra Sikora,
  • Marek Pacholczyk and
  • Katarzyna Kurnicka
  • + 2 authors

20 November 2024

Background: The prevalence of portopulmonary hypertension (PoPH) is relatively low; however, its presence significantly worsens patients’ prognosis. When diagnosed, PoPH can be effectively treated, and specific therapies can lead to a substanti...

  • Review
  • Open Access
29 Citations
14,238 Views
17 Pages

Presentation of Congenital Portosystemic Shunts in Children

  • Atessa Bahadori,
  • Beatrice Kuhlmann,
  • Dominique Debray,
  • Stephanie Franchi-Abella,
  • Julie Wacker,
  • Maurice Beghetti,
  • Barbara E. Wildhaber,
  • Valérie Anne McLin and
  • on behalf of the IRCPSS

11 February 2022

Background: Congenital portosystemic shunts (CPSS) are rare vascular anomalies resulting in communications between the portal venous system and the systemic venous circulation, affecting an estimated 30,000 to 50,000 live births. CPSS can present at...

  • Review
  • Open Access
3 Citations
6,023 Views
12 Pages

16 January 2025

Biliary atresia (BA) is an obliterative disease of the bile ducts affecting between 1 in 10,000–20,000 infants with a predominance in Asian countries. It is clinically heterogeneous with a number of distinct variants (e.g., isolated, Biliary At...

  • Review
  • Open Access
3 Citations
4,413 Views
26 Pages

Diagnosis, Management, and Prognosis of Cystic Fibrosis-Related Liver Disease in Children

  • Dana-Teodora Anton-Păduraru,
  • Alice Nicoleta Azoicăi,
  • Felicia Trofin,
  • Alina Mariela Murgu,
  • Dana Elena Mîndru,
  • Ana Simona Bocec,
  • Codruța Olimpiada Iliescu Halițchi,
  • Gabriela Rusu Zota,
  • Diana Păduraru and
  • Eduard Vasile Nastase

Cystic fibrosis (CF) is a multifaceted disorder predominantly investigated for its pulmonary manifestations, yet patients with CF also exhibit a spectrum of extrapulmonary manifestations, notably those involving the hepatobiliary system. The latter c...

  • Review
  • Open Access
7 Citations
3,189 Views
10 Pages

10 January 2023

Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome are severe pulmonary complications associated with liver cirrhosis (LC) and portal hypertension. Three key pathways, involving endothelin, nitric oxide, and prostacyclin, have been ident...